changes in memory or thinking have raised questions about Alzheimer’s, you no longer have to rely on symptoms and uncertainty alone.
ALZInsights gives you direct access to an FDA-approved Beckman Coulter blood test that measures important biomarkers associated with Alzheimer’s disease. With a simple blood draw, you can gain greater insight into whether Alzheimer’s-associated amyloid changes are present today.
Because knowing earlier may give you something extremely valuable:
Most memory changes don’t necessarily mean Alzheimer’s. But when they begin happening more frequently, it’s natural to wonder.
Until recently, getting meaningful biological information about Alzheimer’s could involve specialized evaluations, brain imaging or more invasive testing. Advances in blood-based biomarkers are changing that. ALZInsights makes this science directly accessible, giving you another important piece of information about what may be happening biologically. You may not be able to know exactly what the future holds.
ALZInsights uses advanced Beckman Coulter technology to measure blood biomarkers associated with the amyloid changes seen in Alzheimer’s disease.
In clinical research evaluating the Beckman Coulter test, among people who received a clear result:
91.2%
of positive result
corresponded with evidence of amyloid pathology.
90.4%
of negative results
corresponded with absence of amyloid pathology.
That means a simple blood draw can provide meaningful biological information that previously could require considerably more complicated testing.
Important: These percentages describe agreement with the presence or absence of Alzheimer’s-associated amyloid pathology. They do not mean the test is “90% accurate at predicting who will get Alzheimer’s.” The distinction matters.
ALZInsights provides insight into what may be happening biologically today — not a prediction of exactly what will happen tomorrow.
The ALZInsights blood test measures two proteins associated with Alzheimer’s disease:
p-Tau217
A form of tau protein strongly associated with biological changes seen in Alzheimer’s disease.
Beta-Amyloid
1-42
A form of amyloid associated with the development of amyloid plaques, one of the biological hallmarks of Alzheimer’s disease.
The test evaluates the relationship between these biomarkers using the p-Tau217 / Beta-Amyloid 1-42 ratio.
This provides information about the likelihood that Alzheimer’s-associated amyloid pathology is present.
ALZInsights helps you see beyond symptoms alone.
This may be the most important reason to consider ALZInsights. A higher-likelihood result does not mean you are destined to develop Alzheimer’s dementia. It cannot tell you whether symptoms will develop, when they might develop or how quickly they might progress. But meaningful health information can change the way you think about the years ahead.
You may decide to take steps to support your brain health. You may seek additional medical evaluation. You may have conversations with your family that you’ve been putting off. You may reconsider when you want to retire. You may finally take the trip you’ve always talked about. You may review your financial, estate or long-term-care plans.
Or you may simply decide to spend more time doing the things — and being with the people — that matter most to you. ALZInsights doesn’t tell you which decisions to make. It gives you information that may help you make those decisions for yourself.
There are Alzheimer’s risk factors you cannot control, including age and genetics. But there are also important aspects of brain and overall health that you can influence. Research increasingly supports a connection between healthy lifestyle behaviors and maintaining cognitive health. You may choose to:
Regular aerobic exercise, strength training and physical activity are associated with better cardiovascular and brain health.
Mediterranean-style and MIND-style eating patterns emphasize vegetables, berries, whole grains, fish, nuts, beans and healthy fats while limiting highly processed foods.
Blood pressure, cholesterol, blood sugar and cardiovascular health are closely connected with brain health.
Consistent, adequate sleep is an important part of maintaining overall and cognitive health.
Regular interaction with friends, family and community can help keep your brain engaged.
Learning, reading, hobbies, games, music and other mentally engaging activities can support cognitive health throughout life.
Protecting your overall health also helps protect your brain.
None of these steps guarantees that Alzheimer’s disease can be prevented or delayed. But healthy lifestyle choices may help reduce the risk of cognitive decline and dementia — and they benefit your overall health regardless of your ALZInsights result.